[2] Ng FM, et al
Note the injection site and date in a simple log
Concerning the first target, currently, no specific drug has been approved
Some medical professionals tout and prescribe BPC-157 as a treatment for various conditions and injuries, including gastric ulcers, irritable bowel syndrome (this sounds plausible, given the role of natural BPC in our stomachs), ligament, tendon, and joint injuries, and erectile dysfunction
Triggers can include factors that disrupt the microbiome, dysregulate the immune system, impair metabolic health, or drive inflammation more broadly
Our better understanding of the weight regulation mechanisms and the role of gut-brain axis on appetite has led to the development of safe and effective entero-pancreatic hormone-based treatments for obesity such as glucagon-like peptide-1 (GLP-1) receptor agonists (RA)